Features

Vision Expo+: a Complimentary, Virtual Extension of Vision Expo Experience Offered April 1-8, 2022

Vision Expo East 2022 Content to be Delivered through the ShopVISION Platform

Beovu, a New Therapy for AMD, Funded for Use in Two Provinces

Novartis announced in December that a new anti-VEGF injection brolucizumab (brand name Beovu) is now funded by the Ontario and New Brunswick Drug Plans for treatment of wet age-related macular degeneration (AMD).

Neurolens Partners with University of Montreal’s Clinique Universitaire de la Vision

Joint projects will fuel Neurolens clinical foundation and future product innovations.

Copenhagen Specs Kicks Off Optics and Eyewear Events for 2022

opened its doors on March 5 to rekindle the independent eyewear business in Northern Europe.

Illusion Lite is Timeless

Certain designs never go out of style. Silhouette’s Illusion Lite model is the embodiment of this type of timeless style that is created from combining fresh ideas with classic looks.

Vision Expo+: a Complimentary, Virtual Extension of Vision Expo Experience Offered April 1-8, 2022

Vision Expo East 2022 Content to be Delivered through the ShopVISION Platform

Beovu, a New Therapy for AMD, Funded for Use in Two Provinces

Novartis announced in December that a new anti-VEGF injection brolucizumab (brand name Beovu) is now funded by the Ontario and New Brunswick Drug Plans for treatment of wet age-related macular degeneration (AMD).

Neurolens Partners with University of Montreal’s Clinique Universitaire de la Vision

Joint projects will fuel Neurolens clinical foundation and future product innovations.

Copenhagen Specs Kicks Off Optics and Eyewear Events for 2022

opened its doors on March 5 to rekindle the independent eyewear business in Northern Europe.

Illusion Lite is Timeless

Certain designs never go out of style. Silhouette’s Illusion Lite model is the embodiment of this type of timeless style that is created from combining fresh ideas with classic looks.

Vision Expo+: a Complimentary, Virtual Extension of Vision Expo Experience Offered April 1-8, 2022

Vision Expo East 2022 Content to be Delivered through the ShopVISION Platform

Beovu, a New Therapy for AMD, Funded for Use in Two Provinces

Novartis announced in December that a new anti-VEGF injection brolucizumab (brand name Beovu) is now funded by the Ontario and New Brunswick Drug Plans for treatment of wet age-related macular degeneration (AMD).

Neurolens Partners with University of Montreal’s Clinique Universitaire de la Vision

Joint projects will fuel Neurolens clinical foundation and future product innovations.

Copenhagen Specs Kicks Off Optics and Eyewear Events for 2022

opened its doors on March 5 to rekindle the independent eyewear business in Northern Europe.

Illusion Lite is Timeless

Certain designs never go out of style. Silhouette’s Illusion Lite model is the embodiment of this type of timeless style that is created from combining fresh ideas with classic looks.

Vision Expo+: a Complimentary, Virtual Extension of Vision Expo Experience Offered April 1-8, 2022

Vision Expo East 2022 Content to be Delivered through the ShopVISION Platform

Beovu, a New Therapy for AMD, Funded for Use in Two Provinces

Novartis announced in December that a new anti-VEGF injection brolucizumab (brand name Beovu) is now funded by the Ontario and New Brunswick Drug Plans for treatment of wet age-related macular degeneration (AMD).

Neurolens Partners with University of Montreal’s Clinique Universitaire de la Vision

Joint projects will fuel Neurolens clinical foundation and future product innovations.

Copenhagen Specs Kicks Off Optics and Eyewear Events for 2022

opened its doors on March 5 to rekindle the independent eyewear business in Northern Europe.

Illusion Lite is Timeless

Certain designs never go out of style. Silhouette’s Illusion Lite model is the embodiment of this type of timeless style that is created from combining fresh ideas with classic looks.